[2022]

1. Weng J*, Zhou Z, Guo L. Comment on Liu et al. Incidence of Type 1 Diabetes May Be Underestimated in the Chinese Population: Evidence From 21.7 Million People Between 2007 and 2017. Diabetes Care 2021;44:2503-2509.. Vol 45; 2022:e12. （JCR:Q1 中科院:一区，IF=17.152）

2. Feng X, Xu S, Weng J*. Marijuana and endothelial dysfunction: new mechanism and therapy. TRENDS MOL MED. 2022. （JCR:Q1 中科院:一区，IF=15.272）

3. Wu X, Xu M, Liu Z, Zhang Z, Liu Y, Luo S, Zheng X, Little PJ, Xu S, Weng J*. Pharmacological inhibition of IRAK1 and IRAK4 prevents endothelial inflammation and atherosclerosis in ApoE(-/-) mice. PHARMACOL RES. 2022;175:106043. （JCR:Q1 中科院:二区，IF=10.334）

4. Luo S, Ran X, Zhang M, Hu J, Yang D, Zhu D, Zhao J, Xiao X, Guo X, Yang T, Huang Q, Liu F, Jing L, Ma J, Zhou X, Ping F, Gu N, Li W, Yang Y, Fang C, Bao W, Zheng X, Yan J, Zhou Z, Weng J*. Pregnancy outcomes in women with type 1 diabetes in China during 2004 to 2014: A retrospective study (the CARNATION Study). J DIABETES. 2022;14(1):5-14. （JCR:Q2 中科院:二区，IF=4.530）

5. Huang R, Zhou X, Chen G, Su L, Liu Z, Zhou P, Weng J*, Min Y. Advances of functional nanomaterials for magnetic resonance imaging and biomedical engineering applications. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. 2022:e1800. （JCR:Q1 中科院:二区，IF=9.423）

6. Su M, Zhao W, Xu S, Weng J*. Resveratrol in Treating Diabetes and Its Cardiovascular Complications: A Review of Its Mechanisms of Action. Antioxidants (Basel, Switzerland). 2022;11(6). （JCR:Q1中科院:二区，IF=7.675）

7. Jiang H, Zhou Y, Nabavi SM, Sahebkar A, Little PJ, Xu S, Weng J*, Ge J. Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis. Frontiers in cardiovascular medicine. 2022;9:925923. （JCR:Q2 中科院:三区，IF=5.846）

8. Ilyas I, Little PJ, Liu Z, Xu Y, Kamato D, Berk BC, Weng J*, Xu S. Mouse models of atherosclerosis in translational research. Trends in Pharmacological Sciences. 2022; DOI:10.1016/j.tips.2022.06.009（JCR:Q1 中科院:一区，IF=17.7）

9. Fang T, Wang H, Pan X, Little PJ, Xu S, Weng J*. Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies. International Journal of Biological Sciences, 2022; In press. （JCR:Q1 中科院:二区，IF=10.8）

10. Xu S, Jin T, Weng J*. Endothelial cells as a key cell type for innate immunity: a focused review on RIG-I signaling pathway. Frontiers in Immunology. 2022; 13:951614 （JCR:Q1 中科院:二区，IF=8.8）

[2021]

11. Bompada P, Goncalves I, Wu C, Gao R, Sun J, Mir BA, Luan C, Renström E, Groop L, Weng J*, Hansson O, Edsfeldt A, De Marinis Y. Epigenome-Wide Histone Acetylation Changes in Peripheral Blood Mononuclear Cells in Patients with Type 2 Diabetes and Atherosclerotic Disease. Biomedicines. 2021 Dec 14;9(12):1908. （JCR:Q2 中科院:三区，IF=4.757）

12. Ling P, Yang D, Gu N, Xiao X, Lu J, Liu F, Zhou Z, Huang Q, Zhao J, Zhang M, Hu J, Luo S, Weng J*, Yan J, Zheng X. Achieving the HbA1c Target Requires Longer Time in Range in Pregnant Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4309-e4317.（JCR:Q1 中科院:二区，IF=6.134）

13. Jiang Z, Ren W, Liang H, Yan J, Yang D, Luo S, Zheng X, Lin GW, Xian Y, Xu W, Yao B, Noble JA, Bei JX, Groop L, Weng J*. HLA class I genes modulate disease risk and age at onset together with DR-DQ in Chinese patients with insulin-requiring type 1 diabetes. Diabetologia. 2021 Sep;64(9):2026-2036. （JCR:Q1 中科院:一区,IF=10.460）

14. Ding Y, Zhou Y, Ling P, Feng X, Luo S, Zheng X, Little PJ, Xu S, Weng J*. Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function. Theranostics. 2021 Sep 9;11(19):9376-9396. （JCR:Q1 中科院:一区，IF=11.600）

15. Ling P, Zheng X, Luo S, Ge J, Xu S, Weng J*. Targeting angiopoietin-like 3 in atherosclerosis: From bench to bedside. Diabetes Obes Metab. 2021 Sep;23(9):2020-2034. （JCR:Q1中科院:二区，IF=6.408）

16. Su M, Xu S, Weng J*. A bibliometric study of COVID-19 research in Web of Science. Pharmacol Res. 2021 Jul;169:105664. （JCR:Q1中科院:二区，IF=10.334）

17. Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, Luo S, Li Z, Liu P, Han J, Harding IC, Ebong EE, Cameron SJ, Stewart AG, Weng J*. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacol Rev. 2021 Jul;73(3):924-967. （JCR:Q1中科院:一区，IF=18.923）

18. Ling P, Yang D, Gu N, Xiao X, Lu J, Liu F, Zhou Z, Huang Q, Zhao J, Zhang M, Hu J, Luo S, Weng J*, Yan J, Zheng X. Achieving the HbA1c Target Requires Longer Time in Range in Pregnant Women with Type 1 Diabetes. J Clin Endocrinol Metab. 2021 Jul 9:dgab502. （JCR:Q1中科院:二区，IF=6.134）

19. Xu S, Liu Y, Ding Y, Luo S, Zheng X, Wu X, Liu Z, Ilyas I, Chen S, Han S, Little PJ, Jain MK, Weng J*. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. Signal Transduct Target Ther. 2021 Jul 12;6(1):266.（JCR:Q1中科院:一区，IF=38.104）

20. Feng X, Chen W, Ni X, Little PJ, Xu S, Tang L, Weng J*. Metformin, Macrophage Dysfunction and Atherosclerosis. Front Immunol. 2021 Jun 7;12:682853.（JCR:Q1中科院:二区，IF=8.786）

21. Jiang Z, Ren W, Liang H, Yan J, Yang D, Luo S, Zheng X, Lin GW, Xian Y, Xu W, Yao B, Noble JA, Bei JX, Groop L, Weng J*. HLA class I genes modulate disease risk and age at onset together with DR-DQ in Chinese patients with insulin-requiring type 1 diabetes. Diabetologia. 2021 May 22.（JCR:Q1中科院:一区，IF=10.460）

22. Ma X, Liu Z, Ilyas I, Little PJ, Kamato D, Sahebka A, Chen Z, Luo S, Zheng X, Weng J*, Xu S. GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential. Int J Biol Sci. 2021 May 11;17(8):2050-2068. （JCR:Q1中科院:二区,IF=10.750）

23. Weng J*, Zeng L, Zhang Y, Qu S, Wang X, Li P, Fu L, Ma B, Ye S, Sun J, Lu W, Liu Z, Chen D, Cheng Z, Liu H, Zhang T, Zou J. Henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes Obes Metab. 2021 Aug;23(8):1754-1764.（JCR:Q1中科院:二区，IF=6.408）

24. Zheng X, Yang D, Luo S, Yan J, Guo X, Yang H, Bao W, Groop L, Dornhorst A, Weng J*; CARNATION Study Group. Association of Implementation of a Comprehensive Preconception-to-Pregnancy Management Plan With Pregnancy Outcomes Among Chinese Pregnant Women With Type 1 Diabetes: The CARNATION Study. Diabetes Care. 2021 Apr;44(4):883-892. （JCR:Q1中科院:一区，IF=17.152）

25. Liang H, Zhang Y, Li M, Yan J, Yang D, Luo S, Zheng X, Yang G, Li Z, Xu W, Groop L, Weng J*. Recognition of maturity-onset diabetes of the young in China. J Diabetes Investig. 2021 Apr;12(4):501-509. （JCR:Q3中科院:三区，IF=3.681）

26. Liu Z, Ma X, Ilyas I, Zheng X, Luo S, Little PJ, Kamato D, Sahebkar A, Wu W, Weng J*, Xu S. Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics. Theranostics. 2021 Mar 4;11(9):4502-4515.（JCR:Q1中科院:一区，IF=11.600）

27. Wu X, Luo S, Zheng X, Ding Y, Wang S, Ling P, Yue T, Xu W, Yan J, Weng J*.Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: A continuous glucose monitoring-based observational study. J Diabetes Investig.2021 Feb 4:10.1111/jdi.13519. （JCR:Q3中科院:三区，IF=3.681）

28. Weng J*, Zeng L, Zhang Y, Qu S, Wang X, Li P, Fu L, Ma B, Ye S, Sun J, Lu W,Liu Z, Chen D, Cheng Z, Liu H, Zhang T, Zou J. Henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes Obes Metab. 2021 Mar 26. （JCR:Q1中科院:二区，IF=6.408）

29. Wang C, Luo S, Yang D, Yan J, Ding Y, Wang S, Ling P, Yao B, Zheng X, Weng J*. Current practice and perspectives of healthcare providers regarding preconception care for women with type 1 diabetes in China. Diabetes Metab Res Rev. 2021 May;37(4):e3454. （JCR:Q1中科院:三区，IF=8.128）

30. Ni L, Wen Z, Hu X, Tang W, Wang H, Zhou L, Wu L, Wang H, Xu C, Xu X, Xiao Z, Li Z, Li C, Liu Y, Duan J, Chen C, Li D, Zhang R, Li J, Yi Y, Huang W, Chen Y, Zhao J, Zuo J, Weng J*, Jiang H, Wang DW. Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial. Nature Public Health Emergency Collection. 2021 Oct;15(5):704-717. （JCR:Q1中科院:三区，IF=9.927）

31. Liang H, Zhang Y, Li M, Yan J, Yang D, Luo S, Zheng X, Yang G, Li Z, Xu W, Groop L, Weng J*. Recognition of maturity-onset diabetes of the young in China. J Diabetes Investig. 2021 Apr;12(4):501-509. （JCR:Q3中科院:三区，IF=3.681）

32. Wong CKH, Wan EYF, Luo S, Ding Y, Lau EHY, Ling P, Hu X, Lau ECH, Wong J, Zheng X, Cowling BJ, Weng J*, Leung GM. Clinical outcomes of different therapeutic options for COVID-19 in two Chinese case cohorts: A propensity-score analysis. EClinicalMedicine. 2021 Feb;32:100743. （JCR:Q1，IF=17.033）

33. Ren W, Yang D, Jiang Z, Xian Y, Huang Q, Luo S, Zheng X, Yan J, Xu W, Yao B, Wang CY, Bei JX, Groop L, Noble JA, Weng J*. Adult-onset type 1 diabetic patients with less severe clinical manifestation have less risk DR-DQ genotypes than childhood-onset patients. Diabetes Metab Res Rev. 2021 Jan;37(1):e3357. （JCR:Q1中科院:三区，IF=8.128）

34. Ling P, Luo S, Zheng X, Cai G, Weng J*. Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study. J Diabetes. 2021 Jan;13(1):89-93. （JCR:Q2中科院:二区，IF=4.530） 

[2020]

35. Zheng X＃, Luo S＃, Sun Y, Han M, Liu J, Sun LY Zhang L, Ling P, Ding Y, Jin T, Liu Z, Weng J*. Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study. Natl Sci Rev.2020;7(10):1527-39. （JCR:Q1中科院:一区，IF=23.178）

36. Pan W, Zheng X, Chen G, Su L, Luo S, Wang W, Ye S, Weng J*, Min Y*. Nanotechnology's application in Type 1 diabetes. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Nov;12(6):e1645. （JCR:Q1中科院:二区，IF=9.423）

37. Weng J*, Zhao J, Zhou Z, Guo X, Zou D, Ji Q, Tong N, Li Q, Zhu J, Li Q, Qin G, Feng P, Yang L, Gao Z, Chen L, Li H, Li Y, Zeng L, Zhu D, Lu J, Luo T, Cui N. Observational study evaluating the effectiveness of physician-targeted education for improving glycemic management of patients with type 2 diabetes (BEYOND II). J Diabetes. 2020 Jan;12(1):66-76. （JCR:Q2中科院:二区，IF=4.530）

38. Qiu L＃, Ling P＃, Yang D, Luo S, Zheng X, Liang H, Yuan Y, Liang G, Xu W, Yao B, Yan J*, Weng J. Current status of metformin in addition to insulin therapy in adult patients with type 1 diabetes mellitus: An analysis from the Guangdong Type 1 Diabetes Mellitus Translational Medicine Study. J Diabetes. 2020 Oct;12(10):754-760. （JCR:Q2中科院:二区，IF=4.530）

39. Xu F, Cao H, Chen Z, Gu H, Guo W, Lin B, Weng J*. Short-term GLP-1 receptor agonist exenatide ameliorates intramyocellular lipid deposition without weight loss in ob/ob mice. Int J Obes (Lond). 2020 Apr;44(4):937-947. （JCR:Q3中科院:二区，IF=4.061）

40.  Xian Y＃, Xu H＃, Gao Y, Yan J, Lv J, Ren W, Huang Q, Jiang Z, Xu F, Yao B, Weng J*. A pilot study of preproinsulin peptides reactivity in Chinese patients with type 1 diabetes. Diabetes Metab Res Rev. 2020 Feb;36(2):e3228.（JCR:Q1中科院:三区，IF=8.128） 

41.Luo S＃, Liu W＃, Liu Z, Zheng X, Hong C, Liu Z, Liu J*, Weng J*. A confirmed asymptomatic carrier of 2019 novel coronavirus. Chin Med J (Engl). 2020 May 5;133(9):1123-1125. （JCR:Q1中科院:三区，IF=6.133）

42. Yang D, Zhou Y, Luo S, Zheng X, Ling P, Qiu L, Xu W, Liang H, Yao B, Weng J*, Yan J*. Clinical Characteristics of Fulminant Type 1 Diabetes Compared with Typical Type 1 Diabetes: One-Year Follow-Up Study from the Guangdong T1DM Translational Medicine Study. J Diabetes Res. 2020 Feb 19;2020:8726268.（JCR:Q3中科院:三区，IF=4.061）

43. Yang D, Yan J, Deng H, Yang X, Luo S, Zheng X, Lv J, Liang W, Hong M, Wu Z, Yao B*, Weng J*, Xu W*. Effects of Metformin Added to Insulin in Adolescents with Type 1 Diabetes: An Exploratory Crossover Randomized Trial. J Diabetes Res. 2020 Dec 24;2020:7419345. （JCR:Q3中科院:三区，IF=4.061）

44. Liu X, Wang L, Xing Y, Engel S, Zeng L, Yao B, Xu W, Chen G, Zhang Y, Zhang R, Liu S, Weng J*, Ji Q*. Efficacy and safety of metformin and sitagliptin-based dual and triple therapy in elderly Chinese patients with type 2 diabetes: Subgroup analysis of STRATEGY study. J Diabetes Investig. 2020 Nov;11(6):1532-1541.（JCR:Q3中科院:三区，IF=3.681）

45. Wu Z, Luo S, Zheng X, Bi Y, Xu W, Yan J, Yang D, Weng J*. Use of a do-it- yourself artificial pancreas system is associated with better glucose management and higher quality of life among adults with type 1 diabetes. Ther Adv Endocrinol Metab. 2020 Aug 25;11:2042018820950146. （JCR:Q2中科院:四区，IF=4.435）

46. Liu H, Yang D, Deng H, Xu W, Lv J, Zhou Y, Luo S, Zheng X, Liang H, Yao B, Qiu L, Wang F, Liu F, Yan J*, Weng J*. Impacts of glycemic variability on the relationship between glucose management indicator from iPro(™)2 and laboratory hemoglobin A1c in adult patients with type 1 diabetes mellitus. Ther Adv Endocrinol Metab. 2020 Jun 8;11:2042018820931664. （JCR:Q2中科院:四区，IF=4.435）

47. Zhou Y＃, Deng H＃, Liu H, Yang D, Xu W, Yao B, Yan J*, Weng J*. Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial. BMJ Open. 2020 Dec 4;10(12):e039400. （JCR:Q2中科院:四区，IF=3.006）

[2019]

48. Zhu M＃, Xu K＃, Chen Y＃, Gu Y＃, Zhang M＃, Luo F＃, Liu Y＃, Gu W＃, Hu J, Xu H, Xie Z, Sun C, Li Y, Sun M, Xu X, Hsu HT, Chen H, Fu Q, Shi Y, Xu J, Ji L, Liu J, Bian L, Zhu J, Chen S, Xiao L, Li X, Jiang H, Shen M, Huang Q, Fang C, Li X, Huang G, Fan J, Jiang Z, Jiang Y, Dai J, Ma H, Zheng S, Cai Y, Dai H, Zheng X, Zhou H, Ni S, Jin G, She JX, Yu L, Polychronakos C, Hu Z*, Zhou Z*, Weng J*, Shen H*, Yang T*. Identification of Novel T1D Risk Loci and Their Association With Age and Islet Function at Diagnosis in Autoantibody-Positive T1D Individuals: Based on a Two- Stage Genome-Wide Association Study. Diabetes Care. 2019 Aug;42(8):1414-1421.（JCR:Q1中科院:一区，IF=17.152）

49. Yan J#, Yao B#, Kuang H#, Yang X, Huang Q, Hong T, Li Y, Dou J, Yang W, Qin G, Yuan H, Xiao X, Luo S, Shan Z, Deng H, Tan Y, Xu F, Xu W, Zeng L, Kang Z, Weng J*. Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease. Hepatology. 2019 Jun;69(6):2414-2426.（JCR:Q1中科院:一区，IF=17.298）

50.  Ding Y＃, Luo S＃, Zheng X＃, Ling P, Yue T, Liu Z, Weng J*. Association between population migration and epidemic control of Coronavirus disease 2019. Sci China Life Sci. 2020 Jun;63(6):936-939. （JCR:Q1中科院:一区，IF=10.372）

51. Wu Z, Jin T, Weng J*. A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope. Sci China Life Sci. 2019 Jan;62(1):46-62. （JCR:Q1中科院:一区，IF=10.372）

52. Yang X＃, Deng H＃, Zhang X＃, Yang D, Yan J, Yao B, Weng J*, Xu W*. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes. Sci China Life Sci. 2019 Nov;62(11):1506-1513.（JCR:Q1中科院:一区，IF=10.372）

53. Yang X＃, Xu W＃, Zhu Y, Deng H, Tan Y, Zeng L, Weng J*. Decreased β-Cell Function is Associated with Cardiovascular Autonomic Neuropathy in Chinese Patients Newly Diagnosed with Type 2 Diabetes. Neurosci Bull. 2019 Feb;35(1):25-33. （JCR:Q2中科院:二区，IF=5.271）

54.  Jia W*, Weng J*, Zhu D*, Ji L, Lu J, Zhou Z, Zou D, Guo L, Ji Q, Chen L, Chen L, Dou J, Guo X, Kuang H, Li L, Li Q, Li X, Liu J, Ran X, Shi L, Song G, Xiao X, Yang L, Zhao Z; Chinese Diabetes Society. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019 Sep;35(6):e3158. （JCR:Q1中科院:三区，IF=8.128）

55.  Xian Y#, Chen Z#, Deng H, Cai M, Liang H, Xu W, Weng J*, Xu F*. Exenatide mitigates inflammation and hypoxia along with improved angiogenesis in obese fat tissue. J Endocrinol. 2019 Aug;242(2):79-89. （JCR:Q2中科院:三区，IF=4.669）

56.  Li X, Xu Z, Ji L, Guo L, Liu J, Feng K, Xu Y, Zhu D, Jia W, Ran X, Chen L, Zhao S, Shi B, Zhu J, Shan Z, Zhou Z, Zeng L, Weng J*; cooperative group on Direct Medical Cost Investigation of Diabetes in Chinese Urban Tertiary Hospitals, Chinese Diabetes Society. Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: A multicenter prospective cohort study. J Diabetes Investig. 2019 Mar;10(2):539-551. （JCR:Q3中科院:三区，IF=3.681）

57.  Pan W, Zhang K, Li H, Wu M, Weng J*. Older adults are prioritized in terms of waiting time under the emergency triage system in Guangzhou, China. GeriatrGerontol Int. 2019 Aug;19(8):786-791. （JCR:Q2中科院:三区，IF=3.387）

[2018]

58. Weng J*, Zhou Z, Guo L, Zhu D, Ji L, Luo X, Mu Y, Jia W; T1D China Study Group. Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ. 2018 Jan 3;360:j5295. （JCR:Q1中科院:一区，IF=93.333）

59. Liu L#, Yan J#, Xu H, Zhu Y, Liang H*, Pan W, Yao B, Han X, Ye J, Weng J*. Two Novel MicroRNA Biomarkers Related to β-Cell Damage and Their Potential Values for Early Diagnosis of Type 1 Diabetes. J Clin Endocrinol Metab. 2018 Apr 1;103(4):1320-1329. （JCR:Q1中科院:二区，IF=6.134）